Start Date
October 1, 2019
Primary Completion Date
October 10, 2019
Study Completion Date
October 10, 2019
Rucaparib
2:1 randomization to receive rucaparib/placebo twice daily for 24 month
Placebo
placebo
Rigshospitalet, Copenhagen
Rigshospitalet, København Ø
Collaborators (1)
Nordic Society of Gynaecological Oncology - Clinical Trials Unit
OTHER
Institute of Cancer Research, United Kingdom
OTHER
Central and Eastern European Oncology Group
OTHER
North Eastern German Society of Gynaecological Oncology
OTHER
Belgian Gynaecological Oncology Group
OTHER
Princess Margaret Hospital, Canada
OTHER
PGOG (Polish Gynaecologic Oncology Group)
UNKNOWN
GSO Global Clinical Research BV
OTHER
GCP-enhederne
UNKNOWN